Pharmacometrics Services Page
Our experienced pharmacometrics services team helps quantify drug-patient interactions, optimize development & regulatory choices.
Clinical Pharmacology Page
Analysis and strategies with the main objective of ensuring a successful drug development program.
Local Therapies for the Global COVID-19 Pandemic Blog Post
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as a therapeutic option for COVID-19 patients.
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? Blog Post
This webinar will explain how pricing has evolved for the rare disease drug market and best practices for supporting value-based pricing.
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs Blog Post
This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive dermal model— MPML MechDermA, a multi-phase, multi-dimensional dermal absorption model.
Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development Blog Post
Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic neuralgia & fibromyalgia.
ICER’s Unsupported Drug Price Increase Report: An Analysis Blog Post
We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported Price Increases.”
Common Questions about Define-XML and the Stylesheet Blog Post
In this blog, we answer common questions about Define-XML and the Stylesheet, including all you need to know for study submission and what version to use.
Trends for Market Access, HEOR, and Real World Evidence Blog Post
This blog reviews trends for using health economics and outcomes research and real-world evidence to evaluate the value of medicines and health technologies.
